Why is Aarti Drugs falling/rising?

As of 17-Jul, Aarti Drugs Ltd's stock price is currently at 515.75, reflecting a decrease of 2.75, or 0.53%. The stock has been underperforming recently, having fallen for the last two days with a total decline of 2.71%. Despite opening with a gain of 3.22% today and reaching an intraday high of Rs 535.2, the overall performance has been weak, particularly as it underperformed its sector by 0.95%. Over the past week, the stock has shown a positive return of 8.34%, and over the last month, it has increased by 14.61%. However, it has generated a negative return of 3.19% over the past year, indicating a longer-term struggle despite some recent gains. Positive factors include high management efficiency and a strong ability to service debt, which may attract institutional investors, as evidenced by a 0.9% increase in their stake.
In the broader market context, Aarti Drugs has underperformed against the benchmark Sensex, which has shown a slight decline of 1.12% over the past week while the stock rose. The stock's performance has been inconsistent, particularly over the last three years, where it has consistently lagged behind the BSE500. Although institutional interest has increased, the company's long-term growth prospects appear limited, with net sales growing at an annual rate of only 5.74% over the past five years. This combination of short-term volatility and long-term underperformance against benchmarks contributes to the current downward movement in Aarti Drugs' stock price.